Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826299) titled 'Warfarin Quality, Adherence, Range, Determinants, and Events in Egyptian Rheumatic Heart Disease and Atrial Fibrillation' on Sept. 13.

Study Type: Observational

Primary Sponsor: Assiut University

Condition: AF

Intervention: Diagnostic Test: INR Diagnostic Test: Time in Therapeutic Range

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2026

Target Sample Size: 90

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07826299

Disclaimer: Curated by HT Syndication....